Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01244763 · ClinicalTrials.gov registry record · Phase 2
Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia
A Phase 2 study, sponsored by Kyntra Bio.
- Completed
- Registry status
- Phase 2
- Development phase
- 145
- Enrollment target
NCT01244763 is a Phase 2 study that has completed, run by Kyntra Bio. The registered enrollment target is 145 participants.
The verdict
NCT01244763, a Phase 2 study, has completed, sponsored by Kyntra Bio.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 145 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate efficacy and safety of roxadustat in the correction of anemia in participants with non-dialysis chronic kidney disease.
Interventions
- DRUG Roxadustat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2010-10-29 |
| Est. Completion | 2012-06-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01244763
The ClinicalTrials.gov registry entry for NCT01244763 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyntra Bio, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Roxadustat is the first listed.
NCT01244763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01244763 about?
NCT01244763 is a clinical study titled "Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia". The primary purpose of this study is to evaluate efficacy and safety of roxadustat in the correction of anemia in participants with non-dialysis chronic kidney disease.
What is the current status of trial NCT01244763?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 145 participants. The study started on 2010-10-29. Estimated completion is 2012-06-13.
What interventions are being tested in trial NCT01244763?
The interventions under investigation include: Roxadustat (DRUG).
Who is sponsoring clinical trial NCT01244763?
This trial is sponsored by Kyntra Bio, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.